Answers are grounded in this paper and cite their sources.
lymphocytes were, for example, seen in squamous cell cancers of various origins. In summary, the variable expression levels of TIGIT and PD-1 in cell types and tissue compartments illustrate the high complexity of immune microenvironments. The high frequency of TIGIT (and PD-1) expressing lymphocytes in cancers highlights considerable opportunities for cotargeting with checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
Blessin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: